PharmaMar Initiates a Phase III Registration Trial with Aplidin(R) in Multiple Myeloma Patients
15-Jun-2010 -
PharmaMar SA (Grupo Zeltia) announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.
This pivotal, international, multicenter Phase III clinical trial, ...
chemical synthesis
clinical trials
multiple myeloma